Sign in

CIK 0001420720

  • Non-accelerated filer
  • Smaller reporting company
Ticker
IBIO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
Operating
EIN
262797813
Phone
+1 302-355-0650
Business address
600 MADISON AVENUE, SUITE 1601, NEW YORK, NY, 10022-1737
Former names
iBio, Inc., iBioPharma, Inc., InB:Biotechnologies, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-10-14 Stoner Elizabeth Director Grant or award · Stock Option (right to buy) +38,000 38,000
2026-10-14 Kropotova Alexandra Director Grant or award · Stock Option (right to buy) +38,000 38,000
2026-10-14 Arkowitz David Director Grant or award · Stock Option (right to buy) +38,000 38,000
2026-10-14 Clark William D Director Grant or award · Stock Option (right to buy) +38,000 38,000
2026-10-14 Parada Antonio Bernardino Guimaraes Director Grant or award · Stock Option (right to buy) +38,000 38,000
2026-10-14 Sender Gary Director Grant or award · Stock Option (right to buy) +38,000 38,000
2026-07-31 Carr Molly Chief Medical Officer Grant or award · Stock Option (right to buy) +430,000 430,000
2026-05-18 Stoner Elizabeth Director Grant or award · Stock Option (right to buy) +60,000 60,000
2026-03-26 Banjak Marc Chief Legal Officer Purchase +12,500 $1.64 $21K 23,566
2026-03-26 Banjak Marc Chief Legal Officer Purchase +1,434 $1.76 $3K 25,000
2026-03-19 Duran Felipe Chief Financial Officer Purchase +24,835 $2.02 $50K 35,974
2026-03-19 Brenner Martin See Remarks Purchase +12,336 $2.02 $25K 30,652
2026-01-28 Banjak Marc Chief Legal Officer Grant or award · Stock Option (right to buy) +146,000 146,000
2026-01-28 Duran Felipe Chief Financial Officer Grant or award · Stock Option (right to buy) +179,000 179,000
2026-01-28 Brenner Martin See Remarks Grant or award · Stock Option (right to buy) +479,000 479,000
2025-11-20 Schimmelpennink Evert B. Director Grant or award · Stock Option (right to buy) +13,500 13,500
2025-11-20 Clark William D Director Grant or award · Stock Option (right to buy) +13,500 13,500
2025-11-20 Sender Gary Director Grant or award · Stock Option (right to buy) +13,500 13,500
2025-11-20 Kropotova Alexandra Director Grant or award · Stock Option (right to buy) +13,500 13,500
2025-11-20 Parada Antonio Bernardino Guimaraes Director Grant or award · Stock Option (right to buy) +13,500 13,500

Page 1 of 7 · 126 trades